Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2025-12-25 @ 1:25 AM
NCT ID:
NCT05939193
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years;
* Diagnosed as pseudomyxoma peritonei, scheduled for cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy under general anesthesia;
* At least 14 days since the last treatment of chemotherapy, radiotherapy, or immunotherapy;
* Consent to participate in this study.
Exclusion Criteria:
* Persistent preoperative atrial fibrillation, or new-onset cardiovascular event (acute coronary syndrome, stroke, or congestive heart failure) in the past 3 months;
* Requirement of vasopressors to maintain blood pressure before surgery;
* Known furosemide hypersensitivity;
* Chronic kidney disease stage 5 or requirement of renal replacement therapy;
* Other conditions that are considered unsuitable for the study participation.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05939193
Study Brief:
Protocol Section:
NCT05939193